Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
Dual association patterns between microglial activation and neuronal health in Alzheimer's disease: a whole-brain MRSI/PET study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Yaoyu, Qian Xiao-Hang, Zhuang Huixiang, Zhang Wenqi, Hu Jialin, Zhao Yibo, Li Yudu, Jin Wen, Xu Chang, Meng Ziyu, Li Wenli, Chen Siyue, Jiang Xu-Feng, Guo Tengfei, Li Ya-Dong, Ye Jian, Liang Zhi-Pei, Li Biao, Zhang Miao, Tang Huidong, Li Yao
Аннотация
INTRODUCTION: Microglial activation can either support neuronal function or exacerbate damage, contributing to Alzheimer's disease (AD) progression. We investigated spatial relationships among microglial activation, neuronal health, and amyloid beta (Aβ) in the AD spectrum.
METHODS: Forty healthy controls, 37 patients with mild cognitive impairment (MCI), and 62 patients with AD underwent whole-brain high-resolution 1H-magnetic resonance spectroscopic imaging (MRSI), [1 8F]DPA-714, and [1 8F]AV-45 positron emission tomography (PET). Regional and voxel-wise analyses assessed changes and associations of microglial activation with N-acetylaspartate (NAA) and Aβ.
RESULTS: MCI and AD patients showed higher microglial activation and lower NAA, correlating with cognitive decline. In controls and MCI, microglial activation correlated positively with NAA and Aβ in early amyloid-accumulating regions. Conversely, negative correlations with NAA emerged in the hippocampus in MCI and extended to temporal and occipital regions in AD.
DISCUSSION: For the first time, we identified two distinct spatial association patterns between [1 8F]DPA-714 PET and NAA, shedding light on the complex interplay between neuroinflammation and neuronal health in AD.
METHODS: Forty healthy controls, 37 patients with mild cognitive impairment (MCI), and 62 patients with AD underwent whole-brain high-resolution 1H-magnetic resonance spectroscopic imaging (MRSI), [1 8F]DPA-714, and [1 8F]AV-45 positron emission tomography (PET). Regional and voxel-wise analyses assessed changes and associations of microglial activation with N-acetylaspartate (NAA) and Aβ.
RESULTS: MCI and AD patients showed higher microglial activation and lower NAA, correlating with cognitive decline. In controls and MCI, microglial activation correlated positively with NAA and Aβ in early amyloid-accumulating regions. Conversely, negative correlations with NAA emerged in the hippocampus in MCI and extended to temporal and occipital regions in AD.
DISCUSSION: For the first time, we identified two distinct spatial association patterns between [1 8F]DPA-714 PET and NAA, shedding light on the complex interplay between neuroinflammation and neuronal health in AD.